Semler Scientific®

❤️💪 Registration is NOW OPEN for Heart & Sole! 💪❤️ February is Heart Health Month, and we’re excited to invite you to “Heart & Sole” – a virtual event that’s all about getting bodies moving and hearts healthy, YOUR way! Whether you: 🏃 Run a few miles, 🧘Stretch it out with yoga, 🏋️ Lift weights at home, 🚶Walk your favorite trail, or 💃 Dance like nobody’s watching – Every move strengthens your body and your heart. 🗓 Join us this February! Click the link below to register now, receive event details, heart-healthy movement tips, and updates as we gear up to move together: 👉 https://lnkd.in/gm7rJ64q Let’s make every step, every stretch, and every heartbeat count – no matter where you are. Move YOUR way. Move for your heart. Move with us this Heart Health Month.   #HeartAndSole #HeartHealthMonth #MoveYourWay #EveryBeatCounts #GetUpAndMove #VirtualHeartHealth #SemlerScientific

We are deeply saddened to hear of the passing of Brian Thompson, CEO of UnitedHealthcare. Our thoughts and prayers are with his family, friends, and the entire UnitedHealthcare team during this time of profound loss. May his legacy of leadership and dedication be remembered and honored. 

Learn why some public companies are rushing to adopt #Bitcoin and the herd mentality that prevents more from doing the same. My latest interview with Eric Semler, Chairman of Semler Scientific®, which announced a Bitcoin treasury strategy in May 2024 only to see their stock $SMLR explode! https://lnkd.in/g2xathAM

MicroStrategy has started a new era of *digital capital*. I had the pleasure of hosting Andrew Kang, CFO of MicroStrategy, Salman Khan, CFO of MARA, Patrick Fleury, CFO of TeraWulf and Renae Cormier, CFO of Semler Scientific® at the Crypto Finance Forum to discuss how corporations can leverage Bitcoin in their treasury. Here's the article and full panel video! Key Takeaways: 1️⃣ Bitcoin is Digital Capital: Preserves corporate balance sheets without decaptializing companies (unlike buybacks or rushed M&A). 2️⃣ Funding Bitcoin with Low-Cost Debt: Cash flow-positive companies can acquire Bitcoin using debt, boosting shareholder value in a way that is accretive in Bitcoin terms. 3️⃣ Volatility as an Advantage: Price volatility enhances stock option value and lowers capital costs through convertible debt—pioneered by MicroStrategy. 4️⃣ Regulatory Clarity: FASB guidance simplifies Bitcoin treasury reporting, encouraging corporate adoption. The future of corporate finance is evolving, and #Bitcoin is at the forefront.

This Veterans Day, Semler extends our heartfelt gratitude to all who have served and protected our country. We’d like to give special recognition to the Veterans who are part of the Semler family— for your dedication, courage, and resilience. Your service to our nation and your ongoing commitment to excellence here at Semler make a difference in all that we do. Today, we honor and celebrate you, and we’re proud to stand beside you. Thank you for all you’ve given and continue to give. #VeteransDay #HonoringOurHeroes #SemlerVeterans #ThankYouForYourService

🚛💪 Excited to be part of the Women in Trucking Accelerate! Conference & Expo in Dallas, Texas! Join us at the Health and Wellness Pavilion for an all-star lineup, including Pfizer, The Little Clinic, Rolling Strong, Fit Drivers, and Semler! 🌟 Professional truck drivers face a higher risk of numerous chronic health conditions, including obesity, hypertension, diabetes, heart disease, and sleep disorders. These conditions create a unique health landscape that can lead to increased vulnerability to diseases such as Peripheral Arterial Disease (PAD). At the Health and Wellness Pavilion, discover how we’re bringing health and wellness to the trucking industry and empowering drivers to stay strong on the road. Visit our booth for resources, insights, and support that make a real impact. Let’s drive wellness together! 🚚💼 🗓️ Save the Date: November 10th - 13th, 2024 📍 Where to Find Us: Booth 1113 QuantaFlo is an FDA-cleared, point-of-care test that may support in the detection of the earliest stages of atherosclerosis in the extremities and all stages of PAD in less than 3-minutes using only a sensor and a laptop or tablet. QuantaFlo accuracy has shown to be higher than cuff-based ABI when evaluated by ultrasound or angiography. It can also detect the earliest blood flow volume changes and is less affected by calcified vessels as seen with the limitations of cuff-based ABI testing method. To learn more about QuantaFlo and PAD, visit us at semlerscientific.com. #WITAccelerate #WomenInTrucking #TruckerHealth #WellnessOnTheRoad#QuantaFlo #HealthcareInnovation #Collaboration #SemlerScientific Reference: https://lnkd.in/gRKCR9gu

🌟 Looking forward to attending DFCon 2024, the leading event for advancing limb preservation and diabetic foot management! 🦶💡 This conference unites healthcare professionals worldwide—podiatrists, vascular surgeons, endocrinologists, wound care specialists, and more—to explore cutting-edge research, treatments, and technologies. We’re excited to showcase how QuantaFlo supports in the early detection of peripheral arterial disease in diabetic patients, which may contribute to better limb preservation outcomes. Our team can’t wait for the interactive workshops, discussions, and networking opportunities! Let’s push the boundaries of limb preservation together! 👩⚕️👨⚕️ 🗓️ Save the Date: November 7th - 9th, 2024 📍 Where to Find Us: Booth 2 QuantaFlo is an FDA-cleared, point-of-care test that may support in the detection of the earliest stages of atherosclerosis in the extremities and all stages of PAD in less than 3-minutes using only a sensor and a laptop or tablet. QuantaFlo accuracy has shown to be higher than cuff-based ABI when evaluated by ultrasound or angiography. It can also detect the earliest blood flow volume changes and is less affected by calcified vessels as seen with the limitations of cuff-based ABI testing method. To learn more about QuantaFlo and PAD, visit us at semlerscientific.com #DFCon2024 #LimbPreservation #DiabeticFootCare #QuantaFlo #HealthcareInnovation #Collaboration #SemlerScientific

🚨 Exciting Announcement! 🚨 We are thrilled to be attending the Live In-Person Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference in Phoenix, Arizona from October 30 - November 2, 2024 at the Sheraton Phoenix Downtown! Join Semler and other healthcare professionals from across the country, including those from the VA, the Department of Defense, and leading organizations like the AAWC, APWC, and more. Looking forward to connecting and learning with this amazing group of professionals. Let's elevate our skills and make a real impact! 🗓️ Save the Date: October 29th – November 2nd, 2024 📍 Where to Find Us: Tabletop 1 QuantaFlo is an FDA-cleared, point-of-care test that may support in the detection of the earliest stages of atherosclerosis in the extremities and all stages of PAD in less than 3-minutes using only a sensor and a laptop or tablet. QuantaFlo accuracy has shown to be higher than cuff-based ABI when evaluated by ultrasound or angiography. It can also detect the earliest blood flow volume changes and is less affected by calcified vessels as seen with the limitations of cuff-based ABI testing method. To learn more about QuantaFlo and PAD, visit us at semlerscientific.com #DesertFootConference #WoundCare #LimbSalvage #Podiatry #HealthcareProfessionals #PhoenixConference #ContinuingEducation #HealthcareAdvancements #SemlerScientific #QuantaFlo

October is Breast Cancer Awareness Month At Semler Scientific, we deliver innovative technologies as solutions that support the early detection and treatment of chronic diseases, such as peripheral arterial disease. This October, we’re applying that same passion to raising awareness for Breast Cancer Awareness Month and supporting those affected by breast cancer. This month let’s come together and spread hope for all the warriors, survivors, and those fighting the battle against breast cancer. 🌺 Early detection saves lives! Regular screenings like mammograms are vital. 🌺Self-examinations and awareness of your body’s changes are crucial steps toward prevention. It’s time to be bold, be aware, and take action. The National Breast Cancer Foundation estimates that in 2024, approximately 310,720 women and 2,800 men in the U.S. will be diagnosed with invasive breast cancer. If detected early, when the cancer is still localized, the five-year relative survival rate is 99%. #BreastCancerAwareness #EarlyDetectionSavesLives #ThinkPink #Pinktober Reference: Breast Cancer Facts & Stats 2024 - Incidence, Age, Survival, & More (nationalbreastcancer.org)

Viva Las Vegas!!! 🎲 We are excited to attend the 2024 Symposium on Advanced Wound Care (SAWC) Fall conference and connect with industry experts to discover the latest advancements in wound care. Don’t miss Semler Scientific at booth 719, where we will be showcasing the latest features of QuantaFlo, our FDA-cleared device for supporting the detection of early and advanced stages of Peripheral Arterial Disease (PAD). Early detection of PAD is crucial for improving outcomes. Come learn how QuantaFlo can make a difference in early PAD detection in diabetic patients and others at risk. 📅 Save the Date: October 3rd – 5th, 2024 📍 Where to Find Us: 719 QuantaFlo is an FDA-cleared, point-of-care test that may support in the detection of the earliest stages of atherosclerosis in the extremities and all stages of PAD in less than 3-minutes using only a sensor and a laptop or tablet. QuantaFlo accuracy has shown to be higher than cuff-based ABI when evaluated by ultrasound or angiography. It can also detect the earliest blood flow volume changes and is less affected by calcified vessels as seen with the limitations of cuff-based ABI testing method. To learn more about QuantaFlo and PAD, visit us at semlerscientific.com See you in Vegas! 🎉 #SAWC2024 #WoundCare #HealthcareInnovation #DiabetesCare #PAD #SemlerScientific #QuantaFlo